Masimo (MASI) Competitors $148.12 -0.67 (-0.45%) Closing price 09/9/2025 04:00 PM EasternExtended Trading$148.50 +0.38 (+0.26%) As of 09:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MASI vs. AMN, VEEV, DXCM, STE, PODD, HOLX, BAX, GMED, TFX, and ITGRShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include AMN Healthcare Services (AMN), Veeva Systems (VEEV), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Teleflex (TFX), and Integer (ITGR). These companies are all part of the "medical" sector. Masimo vs. Its Competitors AMN Healthcare Services Veeva Systems DexCom STERIS Insulet Hologic Baxter International Globus Medical Teleflex Integer AMN Healthcare Services (NYSE:AMN) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Do analysts prefer AMN or MASI? AMN Healthcare Services presently has a consensus target price of $28.25, indicating a potential upside of 36.11%. Masimo has a consensus target price of $193.60, indicating a potential upside of 30.70%. Given AMN Healthcare Services' higher possible upside, equities analysts plainly believe AMN Healthcare Services is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AMN Healthcare Services 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk and volatility, AMN or MASI? AMN Healthcare Services has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Is AMN or MASI more profitable? AMN Healthcare Services has a net margin of -10.75% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat AMN Healthcare Services' return on equity.Company Net Margins Return on Equity Return on Assets AMN Healthcare Services-10.75% 11.09% 3.34% Masimo -24.85%26.54%11.49% Which has higher valuation & earnings, AMN or MASI? AMN Healthcare Services has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAMN Healthcare Services$2.98B0.27-$146.98M-$7.77-2.67Masimo$2.09B3.84-$304.90M-$8.52-17.38 Do insiders and institutionals hold more shares of AMN or MASI? 99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by insiders. Comparatively, 16.9% of Masimo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to AMN or MASI? In the previous week, Masimo had 4 more articles in the media than AMN Healthcare Services. MarketBeat recorded 16 mentions for Masimo and 12 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 1.44 beat Masimo's score of 1.31 indicating that AMN Healthcare Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Masimo 13 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMasimo beats AMN Healthcare Services on 9 of the 17 factors compared between the two stocks. Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.08B$7.02B$5.83B$10.00BDividend YieldN/A1.20%5.28%4.52%P/E Ratio-17.3826.4875.6926.29Price / Sales3.84136.49518.33172.80Price / Cash23.2922.1637.2059.76Price / Book7.605.0411.516.41Net Income-$304.90M$176.38M$3.28B$270.56M7 Day Performance8.30%1.49%1.45%3.13%1 Month Performance2.34%4.82%11.30%9.74%1 Year Performance28.81%9.41%59.09%28.17% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo4.6972 of 5 stars$148.12-0.5%$193.60+30.7%+33.0%$8.08B$2.09B-17.385,600Positive NewsAMNAMN Healthcare Services4.4718 of 5 stars$20.77+3.6%$28.25+36.0%-54.6%$796.38M$2.98B-2.672,968Positive NewsVEEVVeeva Systems4.3626 of 5 stars$268.85-1.3%$299.88+11.5%+26.9%$43.99B$2.75B53.847,291Positive NewsAnalyst UpgradeDXCMDexCom4.9472 of 5 stars$75.34+0.3%$99.89+32.6%+12.5%$29.54B$4.03B52.3210,300News CoveragePositive NewsAnalyst DowngradeInsider TradeSTESTERIS4.9237 of 5 stars$245.26+0.2%$273.50+11.5%+1.3%$24.14B$5.46B37.5617,787Positive NewsPODDInsulet4.2163 of 5 stars$339.88+0.7%$332.71-2.1%+61.0%$23.93B$2.07B103.313,900News CoveragePositive NewsAnalyst ForecastInsider TradeHOLXHologic4.8711 of 5 stars$67.12+0.8%$78.00+16.2%-19.3%$14.93B$4.03B27.857,063News CoveragePositive NewsAnalyst UpgradeBAXBaxter International4.8568 of 5 stars$24.72+1.3%$30.11+21.8%-37.6%$12.68B$10.64B-82.3838,000Positive NewsGMEDGlobus Medical4.869 of 5 stars$61.26+0.2%$87.64+43.1%-15.6%$8.27B$2.52B19.095,300Positive NewsTFXTeleflex4.6326 of 5 stars$126.58+0.3%$141.57+11.8%-46.8%$5.59B$3.05B29.7814,100Positive NewsAnalyst UpgradeITGRInteger4.1616 of 5 stars$107.58+0.2%$140.25+30.4%-15.3%$3.78B$1.72B47.3911,000Positive News Related Companies and Tools Related Companies AMN Healthcare Services Alternatives Veeva Systems Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Hologic Alternatives Baxter International Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASI) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNVDA: The cracks are beginning to showThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredPOP QUIZ: What’s the #1 indicator of a stock’s success? (Nope, not earnings or sales)What indicator do you think is the #1 predictor of stock market success? Most would guess earnings or sales...The Oxford Club | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.